TP53INP2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-84309
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the C-terminal region of human TP53INP2. Peptide sequence: RLQRARQRAERHALSAKAVQRQNRARESRPRRSKNQSSFIYQPCQRQFNY The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for TP53INP2 Antibody
Western Blot: TP53INP2 Antibody [NBP2-84309]
Western Blot: TP53INP2 Antibody [NBP2-84309] - WB Suggested Anti-TP53INP2 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:312500. Positive Control: Human heartWestern Blot: TP53INP2 Antibody [NBP2-84309]
Western Blot: TP53INP2 Antibody [NBP2-84309] - Host: Rabbit. Target Name: TP53INP2. Sample Tissue: Human A549 Whole Cell. Antibody Dilution: 1ug/mlApplications for TP53INP2 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: TP53INP2
Alternate Names
C20orf110, chromosome 20 open reading frame 110, diabetes and obesity regulated, dJ1181N3.1, DKFZp434B2411, DKFZp434O0827, DOR, FLJ21759, FLJ23500, p53-inducible protein U, PINHPIG-U, tumor protein p53 inducible nuclear protein 2, tumor protein p53-inducible nuclear protein 2
Gene Symbol
TP53INP2
Additional TP53INP2 Products
Product Specific Notices for TP53INP2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...